All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for NOVAVAX, INC. · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $50,000.00 income · posted Apr 15, 2026

Official filing document

Bills named in this filing 1

HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Lobbying activity 1

Health Issues

Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.